Keywords
De novo protein evolution, novel genes, de novo genes, gene emergence, protein-coding genes
De novo protein evolution, novel genes, de novo genes, gene emergence, protein-coding genes
The question of how new genes come about has been a major research theme in evolutionary biology since the discovery that different species’ genomes contain varying numbers of genes. This question is difficult to answer, since emerging genes cannot easily be “caught in the act”. Ohno1 gave the first comprehensive answer: new genes can emerge via the duplication of old genes. Consequently, gene duplication was thought to be the only mechanism of gene birth for many years2. However, the discovery of so-called orphan genes in newly sequenced genomes raised doubt about the general validity of Ohno’s model of gene duplication. Orphan genes are genes that lack detectable homologs outside of a species or lineage. To explain the presence of orphans under the assumption that new genes emerge only via duplication, one has to assume gene loss in all other lineages or a phase of highly accelerated evolution that leads to the loss of detectable sequence similarity3. Yet convergent gene loss in many independent lineages is unlikely — especially given the high number of orphan genes — and it is difficult to explain why so many genes would experience prolonged phases of accelerated evolution4. On the contrary, it would be expected that genes that do not experience any selective pressure — which is required here for accelerated evolution — would be pseudogenized eventually, i.e. not be transcribed anymore.
These inconsistencies and further observations suggested that there could be other mechanisms of gene emergence5,6, for example de novo gene emergence, a process in which a new gene evolves from a previously non-genic sequence. The product of this process can be an RNA gene or a protein-coding gene. The possibility of de novo gene emergence has long been disputed, with many claiming that it is impossible for an intergenic, random open reading frame (ORF) to encode a functional protein (reviewed in 4,7). But, despite these open questions regarding the exact mechanism of de novo gene birth, many recent studies report de novo emergence of protein-coding genes5,6,8–19.
In general, genes without detectable homologs can be summarized under the term novel genes. These genes can also be called orphan genes, or — more precisely — species-/lineage-specific genes. The term de novo describes a specific subclass of novel genes, namely genes emerging from non-genic sequences20. Additionally, one has to discriminate between functional genes and other classes of sequences. A de novo transcript can be any species-specific transcript that is homologous to an intergenic sequence in outgroups. De novo transcripts can be seen as putative de novo genes (see also Figure 1). The term protogene also describes intergenic transcripts or ORFs that are situated on a continuum between non-genic sequences and functional genes21 (see also Figure 1). At the genic end of the spectrum, the term de novo gene describes a functional gene that has emerged de novo. De novo genes can either code for a protein or be functional as RNAs22. Here, we will use the term de novo gene to describe de novo genes of unknown coding status and de novo protein-coding gene to describe de novo-emerged genes that likely produce a functional protein product.
The first step necessary to determine de novo status of a gene is to verify that no homologous sequences are present in outgroups. This homology search is often performed using BLAST or similar alignment search tools, for example against non-redundant protein databases containing all known protein sequences. Usually, an e-value cutoff between 10−3 to 10−5 is used for this step to ensure that no spurious, suboptimal alignments are taken into account4. If this homology search does not find any homologs outside of the analyzed species, the query gene has successfully been confirmed to be a novel gene. This definition states only that there are no homologous sequences outside of a certain phylogenetic group. Calling a gene novel does not imply any knowledge about the emergence mechanism of the gene.
To additionally determine de novo gene origin, the homologous non-coding outgroup DNA sequence has to be retrieved14,23. The outgroup homologous sequence can be recovered using synteny information about the position of orthologous neighbor genes. Another possibility is searching the target gene sequence in outgroup genomes using alignment search tools such as BLAST4,23. A number of different types of de novo genes can be discriminated depending on the type of sequence that the genes likely emerged from23.
Problems in de novo gene identification and annotation. In the past24 and also more recently25,26, studies have raised questions regarding the reliability of homology-based searches of novel genes. Specifically, short and fast-evolving genes were proposed to lose detectable sequence similarity faster than other genes. As a result, shorter genes would be expected to be over-represented among young genes, thereby biasing the results of studies of genes of different ages24–26. Doubts have been raised as to which fraction of genes would actually be affected by this effect27. Also, this should not be a problem for de novo genes defined by the methods summarized here. The possibility that the examined gene is actually a fast-evolving old gene is excluded, since for a confirmed de novo gene the homologous non-genic outgroup sequence has to be determined. Additionally, doubts have been raised regarding the accuracy of the initial claims of the unreliability of homology detection28.
Another challenge is the previously mentioned identification of a non-coding sequence in an outgroup which is clearly homologous to the suspected de novo gene. In non-coding DNA, homology signals disappear very quickly, since non-coding sequences accumulate mutations faster than coding sequences. Because of this, it is often impossible to determine the homologous non-coding sequence in an outgroup. This problem increases with gene age. As a result, it is often not possible to determine the mechanism of origin, especially for older genes.
Additionally, there are methodological difficulties in the annotation of de novo and also all other types of novel genes4. These problems could lead to a systematic underestimation of the number of de novo/novel genes. The problems are caused by genome annotation also being based on sequence homology29. As de novo/novel proteins per definition do not possess any homologs, they cannot be annotated based on that criterion and their number is likely to be underestimated. Other common criteria such as minimum expression strength and the presence of multiple exons could also contribute to the problem, as these criteria do not represent intrinsic requirements for gene existence and are biased against de novo/novel genes18. Nevertheless, the criteria might be necessary to prevent an over-annotation of spurious transcripts as genes, but they also make it impossible to identify all de novo genes. Recent studies on de novo protein-coding genes also employed such thresholds on exon number and expression strength to produce a more robust data set15,17,18.
Conceptually, de novo genes can evolve via two different mechanisms. The first mechanism is transcription-first, where an intergenic sequence gains transcription before evolving an ORF20,30. Recently, this has been shown to happen frequently when long non-coding RNAs (lncRNAs) become protein coding17,31,32. Consequently, lncRNAs could represent an intermediate step in the evolution of a protein-coding gene33. The second model is ORF-first, in which an intergenic ORF gains transcription20,30. Such a transcribed de novo ORF has been proposed to represent an intermediate step in gene emergence, a protogene (Figure 1). High turnover of intergenic transcription34 likely plays a role in de novo gene emergence by exposing novel transcripts to selection. Transposable elements can also play a role in de novo gene emergence35. Additionally to whole proteins, terminal domains can also emerge de novo33,36. One model regarding the emergence of novel domains is the “grow slow and molt”, in which reading frames get extended gradually and eventually gain a structure and function37,38.
An additional process that could play a role during de novo protein-coding gene emergence is a (partial) revival of pseudogenized gene fragments. This possibility has already been proposed by Ohno1. Regarding de novo protein-coding gene emergence, it seems possible that fragments of a pseudogenized gene that has been somewhat eroded by drift could become part of a de novo ORF later on. These fragments could provide a starting point for de novo protein emergence by providing remnants of structural elements. For all of these models, there are several consistent findings, but none of the models is, as yet, supported by a comprehensive set of data from diverse sources and corresponding experimental data.
De novo gene death. Orphan genes seem to generally have a high loss probability14,39 that seems to be negatively correlated with gene age40,41. The cause of this correlation is not yet well understood. It seems possible that young orphan genes have not yet gained a function or do not perform transient functions. It is also not clear yet how much of these findings can be transferred to de novo genes, as the studies on this topic examined all novel genes of different emergence mechanisms jointly.
A number of studies have examined the functions of orphan genes, some of which may represent de novo-emerged genes. Findings on orphan gene functions include involvement of orphan genes in the stress response21,42, rapid adaptation to changing environments as well as species-specific adaptations43,44, and limb regeneration45. Additionally, novel genes were found to quickly gain interaction partners and become essential39,46.
Fewer studies, however, have examined the functions of systematically verified de novo-emerged genes. Generally, a high number of de novo genes was found to be expressed specifically in the testes, at least in Drosophila species5,6 and primates18, as well as in plant pollen16,47. In the mouse, a de novo-emerged RNA gene was found to raise reproductive fitness22. Another study found de novo genes to play a role in the Arabidopsis stress response12. More specifically, one de novo ORF was found to play a role in male reproduction in Drosophila48. Reinhardt et al.48 also presented findings suggesting a role of de novo genes in developmental stages of Drosophila. However, these findings have to be interpreted carefully, as the RNAi method used has been shown to produce unreliable results49,50. A few other examples of functional de novo genes have been found30, while others were not able to determine specific functions of identified de novo-emerged genes15. The available data suggest that de novo-evolved genes can play a role in many different processes from reproduction to the stress response.
Recently, one study analyzed the function of two putative de novo protein-coding genes in Drosophila melanogaster51. The two analyzed genes were found to be essential for male reproduction and to have testis-biased expression. Both genes are located inside introns of other, older genes with homologs in outgroups. However, the de novo origin of the analyzed genes could not be confirmed with certainty owing to the outgroup homologous sequences not being identifiable (see above for a general description of this problem).
Little is known about the protein structures of de novo proteins. Some studies have found a high amount of intrinsic protein disorder52 in very young genes15,51,53, while others have not21. A priori, it seems unlikely that de novo-emerging proteins have a well-defined protein structure. Intuitively, it seems more likely for random sequences to be intrinsically disordered instead (see Figure 1). Nevertheless, disordered regions can also be highly functional52,54 and could as such also represent an evolved state.
Also, contrary to intuition, at least semi-random (restricted alphabet) proteins appear to sometimes have a defined secondary structure55,56. Additionally, the existing protein structure families appear to have multiple origins57. This finding suggests that the emergence of new protein structures is at least possible. Avoidance of misfolding and aggregation, on the other hand, have been proposed to be driving forces of protein evolution58,59. This observation and the existence of de novo protein-coding genes suggest that de novo proteins have the potential to exhibit a defined structure.
Despite many advances in recent years, many open questions remain regarding de novo protein-coding genes. One understudied field is the functional characterization of protein-coding de novo-emerged genes. One non-coding RNA gene has been found to have a role in reproduction in the mouse22, and additionally one likely protein-coding gene has been found to be essential for reproduction in Drosophila48. However, beyond that, there is a substantial lack of data. Consequently, it remains unclear how de novo protein-coding genes gain their function and if there are some roles that they are more or less likely to carry out.
As described above, the structural characterization of de novo protein-coding genes is still an open question. Previously, ambiguous signals have been found regarding the role of intrinsic disorder in de novo-emerging protein-coding genes15,21. It would be important to experimentally verify the structure — or lack thereof — of de novo protein-coding genes. Here it is of major interest to determine the proportion of intergenic ORFs with folding potential and also what the implications are for the retention of such ORFs. This would allow further conclusions about de novo gene emergence: if most intergenic, random ORFs are foldable, function would seem to be the bottleneck of de novo protein-coding gene retention. On the other hand, if most confirmed de novo genes are folding, but most intergenic ORFs do not possess folding potential, folding potential would be a bottleneck of de novo protein-coding gene emergence and retention.
Another unsolved problem is how to find specific annotation thresholds for orphans/de novo genes4. As described above, a number of their properties make de novo genes difficult to annotate and to be distinguished from transcriptional noise. One solution would be to generate high-quality proteome data using e.g. mass spectrometry. However, this process is still highly expensive and might also not be able to generate a complete picture, since low-frequency peptides are hard to detect60. Another method is ribosome profiling, which uses ribosome occupancy of sequences as a measure of translation. This method has been successfully used to show that some transcripts that were previously classified as non-coding could in fact be translated61.
Additionally, patterns of selection, e.g. measured in the ratio of non-synonymous to synonymous mutations, can be used to infer the coding status of sequences. Genes with a higher fraction of synonymous mutations compared to non-synonymous mutations can be expected to be protein coding and under purifying selection17,20. However, these measures require a number of orthologs to be present, which makes them of limited use for novel genes. Another possibility is the use of population data for the same purpose, which circumvents the problem of the unavailability of orthologs for novel genes.
As it stands, studies mostly have to rely on arbitrary cutoffs15,17 and thus might miss a number of genes. It would be of major interest to be able to differentiate de novo genes and protogenes from transcriptional noise. Recent research has already shown that small ORFs (smORFs) can play a functional role62,63, and consequently it seems quite likely that also very short novel ORFs could be functional. This question also touches upon the problem of differentiating lncRNAs from protein-coding genes, which is often performed via an ORF length cutoff17,32.
Going forward, it is of major interest to fully characterize a large number of de novo genes in terms of evolutionary, functional, and structural history to be able to draw some general conclusion about their evolution. Specifically, it is of major interest to determine whether a functional role is an exception for protogenes or if most expressed ORFs have a functional impact which mostly does not affect the fitness of the organism at a significant level. If most expressed ORFs have only a negligible fitness effect, they would mostly evolve via drift. Two closely related questions are how and when de novo proteins gain their function: are de novo genes usually functional from the time point of their emergence, or do they gain a cellular task only after a period of drift?
In recent years, an increasing number of studies confirmed a major role of de novo gene emergence in the evolution of new protein-coding genes. The functional description of de novo-emerged genes is still lacking, but more general findings for orphan genes suggest that novel genes have a broad functional potential. However, the more detailed functional as well as structural characterization of de novo-emerged protein-coding genes remains one of the big open questions. An interesting recent finding was the confirmation of lncRNAs as an intermediate step in de novo protein-coding gene evolution. This finding offers a solution to two of the big questions in de novo gene evolution — how and why do intergenic sequences gain transcription? However, these findings also touch upon a difficult problem in studying de novo genes: how can protein-coding genes be distinguished from non-coding ones? This problem is exacerbated by recent findings that show that very short ORFs can also be functional63. Tackling all of these problems and integrating them into detailed studies of the emergence, structure, and function of de novo protein-coding genes will provide new, interesting insights and allow for a deeper understanding of the inner workings of the evolution of de novo protein-coding genes.
The authors would like to thank Andreas Lange and the reviewers for valuable feedback on the manuscript.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 1 19 Jan 17 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)